GL1X · GenesisL1 explorer

Research workbench

T. cruzi fpps in complex with 3-((4-(BENZO[D]THIAZOL-2-YL)PIPERAZIN-1- YL)METHYL)-1H-indol-5-ol

Analyse T. cruzi fpps in complex with 3-((4-(BENZO[D]THIAZOL-2-YL)PIPERAZIN-1… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6R0A
Type
protein
Length
358 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Farnesyl diphosphate synthase
UniProt
Q8WS26
Ligands
JMT, ZN, SO4
Pockets
2 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 74% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFarnesyl diphosphate synthaseprotein35874% helix, 2% strandQ8WS26

Ligands and binding sites

  • JMT · 3-[[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]methyl]-1~{H}-indol-5-ol · ligand · 2 copies · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A
  • SO4 · Sulfate ion · ion · chains A
  • ACT · Acetate ion · additive

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16200.760.8259ZN, SO4
2520.260.7315empty

Compared structures

  • 6R0A · T. cruzi FPPS in complex with 3-((4-(benzo[d]thiazol-2-yl)piperazin-1-yl)methyl)-1H-indol… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.